Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity (2023)

This is a place to post research you have done on the topic along with your conclusions.
User avatar
anacleta
Posts: 652
Joined: Fri Jan 23, 2015 5:47 am
Contact:

Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity (2023)

Unread post by anacleta »

Article
Open Access
Published: 23 January 2023

Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study

Christelle Langley, Sophia Armand, Qiang Luo, George Savulich, Tina Segerberg, Anna Søndergaard, Elisabeth B. Pedersen, Nanna Svart, Oliver Overgaard-Hansen, Annette Johansen, Camilla Borgsted, Rudolf N. Cardinal, Trevor W. Robbins, Dea S. Stenbæk, Gitte M. Knudsen & Barbara J. Sahakian
Neuropsychopharmacology (2023)

Abstract

Several studies of the effects on cognition of selective serotonin reuptake inhibitors (SSRI), administered either acutely or sub-chronically in healthy volunteers, have found changes in learning and reinforcement outcomes. In contrast, to our knowledge, there have been no studies of chronic effects of escitalopram on cognition in healthy volunteers. This is important in view of its clinical use in major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). Consequently, we aimed to investigate the chronic effect of the SSRI, escitalopram, on measures of ‘cold’ cognition (including inhibition, cognitive flexibility, memory) and ‘hot cognition’ including decision-making and particularly reinforcement learning. The study, conducted at the University of Copenhagen between May 2020 and October 2021, used a double-blind placebo-controlled design with 66 healthy volunteers, semi-randomised to receive either 20 mg of escitalopram (n = 32) or placebo (n = 34), balanced for age, sex and intelligence quotient (IQ) for at least 21 days. Questionnaires, neuropsychological tests and serum escitalopram measures were taken. We analysed group differences on the cognitive measures using linear regression models as well as innovative hierarchical Bayesian modelling of the Probabilistic Reversal Learning (PRL) task. The novel and important finding was that escitalopram reduced reinforcement sensitivity compared to placebo on both the Sequential Model-Based/Model-Free task and the PRL task. We found no other significant group differences on ‘cold’ or ‘hot’ cognition. These findings demonstrate that serotonin reuptake inhibition is involved in reinforcement learning in healthy individuals. Lower reinforcement sensitivity in response to chronic SSRI administration may reflect the ‘blunting’ effect often reported by patients with MDD treated with SSRIs. Trial Registration: NCT04239339.


Full text: https://www.nature.com/articles/s41386-022-01523-x


articles in the media talk about it:


- Antidepressants like SSRI can cause ‘emotional blunting’, according to new research
New research into the effects of antidepressants like SSRIs show that the medicine can cause a lack of enjoyment along with depression and emotional pain.
https://www.yorkshireeveningpost.co.uk/ ... ch-3997763

- Antidepressants can cause ‘emotional blunting’, study shows
Volunteers less responsive to positive and negative feedback after course of serotonin-controlling drugs
https://www.theguardian.com/society/202 ... ting-study
Post Reply

Who is online

Users browsing this forum: No registered users and 0 guests